In 1955, Waksman and Adams' induced experimental allergicneuritis(EAN) in rabbits by the subcutaneous injection of homologous or heterologous peripheral nerve in adjuvant. The same condition has subsequently been produced in other experimental animals. The clinical course of EAN and the pathological changes in peripheral nerves and roots are very similar to those in the naturally occurring human disease, acute idiopathic polyneuropathy (AIP, Guillain-Barrd syndrome). 2 The finding of cellular infiltrates in association with demyelinated nerves in both conditions led most investigators to conclude that pathological changes were secondary to a cell mediated autoimmune reaction against peripheral nerve myelin.3-5 Studies on cellular immune function in vitro on patients with AIP supported this conclusion.6 7 Antimyelin activity had also been demonstrated in EAN and AIP serum in early studies but the activity in the serum correlated poorly with clinical severity of the diseases.1 8 9 In humans, serum antimyelin activity has been observed occasionally in normal people and in patients with other diseases, both neurological and non-neurological.'0 11
In vivo demyelination of rat sciatic nerve by injection of EAN serum directly into the nerve was first reported by Saida and co-workers in 1977.12 This finding reopened the question of the role of humoral immunity in autoimmune peripheral demyelination. In addition, several reports have been of dispersion of the muscle action potential and published more recently describing the benefits of plasmapheresis on the recovery of patients with AIP, chronic relapsing polyneuropathy and chronic progressive polyneuropathy. [13] [14] [15] [16] [17] [18] [19] [20] In these reports dramatic recovery was described in some patients following plasmapheresis. However, the procedure is not without risks,2' and the natural history of AIP is such that controlled trials will be necessary to prove the efficacy of plasmapheresis in this condition. In the present study, plasmapheresis has been performed in rabbits with EAN in order to determine if it was effective in preventing the development of severe paralysis.
Materials and methods
Thirty rabbits of mixed strains weighing from 2-2 to 4 1 kg were used in the experiment. They were kept in wire cages and given a standard diet and water ad libitum. All of the rabbits were aged three months or more. They were randomly divided into two groups, one of which was a control group (14 animals) and the other group was plasmapheresed (16 animals). Bovine peripheral nerve or root was obtained from a local abbatoir. After the fat and connective tissue were carefully removed from the nerve, it was frozen in liquid nitrogen and crushed to a fine powder. Normal saline (10 ml) was added to 10 mg of crushed nerve and suspended in 20 ml of Freund's complete adjuvant. On Day 0, each of the rabbits was anaesthetised with 100-150 mg of intravenous propanidid (Epontal) and injected subcutaneously with 3 ml of the above suspension. This dose was divided between the foot pads (0-25 ml) and four separate sites on the back (0 5 ml). was removed and the cells were reinjected through the venous catheter. The procedure was repeated so that during one session a total of either 1/2 or 1/3 of the blood volume was removed. Some of the animals were given 10% calcium gluconate (1 ml/kg) and in the later groups oxygen was given during the procedure. Usually, no fluid replacement was used although some rabbits were given 20 ml of normal saline intravenously at the end of the procedure. After the session the artery was tied off proximal to the tip of the catheter and the catheter removed. The duration of the procedure was 1-1 hrs. At Days 13 to 15, a second plasmapheresis was carried out exactly as described above using the other ear. For technical reasons usually only two plasmaphereses were possible although one animal had three and another had four plasmaphereses at weekly intervals. Technical problems arose when trying to insert a catheter proximal to the previous catheter site since the artery had usually thrombosed.
The animals were weighed at the beginning of the experiment and then at approximately weekly intervals thereafter. Some of the plasmapheresed animals were also weighed before and after the procedure. Clinical evaluation was also carried out at weekly intervals by two independent observers. The following clinical 
Electrophysiological techniques
In the fifth week, neurophysiological studies were performed after inducing anaesthesia with 100-150mg intravenous propanidid followed by a mixture of halothane and oxygen by face mask. Motor conduction velocity was recorded in both sciatic nerves of each animal. The compound action potential was recorded from the small muscles of the foot through a pair of subcutaneous steel needle electrodes; the proximal recording electrode was inserted into the muscle mass and a remote electrode was inserted distally into one of the toes of the same foot. The nerve was stimulated percutaneously through a pair of needle electrodes separated by about I cm at the level of both the ankle and the sciatic notch. The stimulus was a square wave of duration 02 ims. derived from a Devices stimulator.
Action potentials were amplified, displayed on an oscilloscope and photographic recordings made on polaroid film. To prevent heat loss during recordings the animals were placed beneath a lamp. The temperature of the limb was measured with a thermistor at each examination and ranged from 34°to 37°C.
(I ,tm) were stained with toluidine blue and prepared for light microscopy.
Results

COMPLICATIONS OF PLASMAPHERESIS
Of the 16 animals in the plasmapheresed group, six died as a result of the procedure. Five animals died at 7, 8, 12, 19 and 21 days respectively during the procedure. None was weak at the time and only one had weight loss. Four of those five animals became restless, began to hyperventilate and assumed an opisthotonic posture immediately prior to death. The fifth animal had a chest infection prior to the procedure and died suddenly while being plasmapheresed. A hypoxic insult was suspected in all cases. The animals in the later groups were given oxygen during the procedure and this improved their survival and well-being. No postmortem studies were performed. The sixth death occured 24 hrs after the first plasmapheresis. The animal was noted to be well at 20 hrs, but shortly thereafter, began falling to the right and was unable to walk. Because of its deteriorating condition, it was killed.
CLINICAL ASSESSMENT
The average weight of both plasmapheresed and control groups at the beginning of the experiment was 3-3 kilograms. The percentage change in body weight from Day 0 to 2-3 weeks was -3 % (SD, 10 %) in the control animals compared to -2 % (SD, 7 %) in those animals that were plasmapheresed, an insignificant difference. However, from 2-3 weeks to the fifth week, the control animals had a further change in weight of -8 % (SD, 70%) compared to -2% (SD, 5%) in the plasmapheresed group. The difference was significant (p < 0-05).
There were also differences on clinical assessment. When examined at 2-3 weeks, five of the 14 control animals had definite weakness whereas none of the plasmapheresed animals was weak. At five weeks, 11 of the surviving 13 control animals had definite and often marked weakness, but only three of the nine plasmapheresed animals were definitely weak (table 1) . Two animals, one in the control group and Plasniapheresed group Significant differences* In the neurophysiological studies at five weeks no differences between plasmapheresed and control groups in distal motor latency or conduction velocity of the sciatic nerves were found. This is not surprising since previous experimental work has shown that considerable demyelination can be present in animals with little change in conduction velocity. 23 However, dispersion of the action potential, which is a more reliable indicator os the degree of demyclination, was more marked in the control group. In the pathological studies of the sciatic nerve and lumbar nerve roots more demyelination was observed in the control group than in the plasmapheresed group which showed no definite areas of demyelination in the sections that were studied. Since some of the plasmapheresed animals were weak, demyelination was certainly present. The disease is patchy, and it is possible that we found more lesions in the control group by chance since more areas were affected than in the nerves of the plasmapheresed group.
The method of plasmapheresis used in this study was not very satisfactory because of the high mortality rate directly related to the procedure. Only one description of a method of plasmapheresis of experimental animals has appeared in the literature.24 This method was similar in principle to ours except that a scalp vein needle was directly inserted into the central ear artery of the rabbit. When we tried this method the needle caused vasoconstriction and we were unable to plasmapherese the volumes described in the report. The other factor contributing to the high mortality rate may have been the short time (1 to 2 hrs) taken for plasmapheresis. This may have been too fast for some rabbits, but it was difficult to restrain the animals for longer periods. The other disadvantage of our technique was the number of possible plasma exchanges which was usually limited to two because of thrombosis of ear arteries. Despite the technical problems encountered in plasmapheresis of rabbits, the present study has demonstrated that prophylactic plasma exchange mitigates the severity of the weakness and the degree of demyelination caused by EAN. These findings lend support to the work of Saida et a/12 that suggest that a serum factor is important in the pathogenesis of the disease. Further studies are in progress to assess the value of plasmapheresis in influencing the course of the illness in animals after EAN is clinically established, and to characterise serum factors responsible for demyelination in EAN. 
